Allen v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Curtis Allen |
| Sanofi US Services, Inc., GlaxoSmithKline, LLC, Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc. |
| 2:2020cv02141 |
| February 28, 2020 |
| US District Court for the Western District of Tennessee |
| Charmiane G Claxton |
| Sheryl H Lipman |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 20, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| NOTICE DETAILS: Case transferred from Tennessee Western has been opened in Southern District of Florida as case 9:20-cv-80461, filed 03/20/2020 (jae) |
| Filing 7 CONDITIONAL TRANSFER ORDER (CTO-5) MDL No. 2924. Signed by John W. Nichols, Clerk of Panel on 3/18/2020. (Attachments: #1 Transmittal Notice)(agj) |
| Filing 6 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services, Inc.. The filer has been notified electronically that the summons has been issued, and the new docket entry reflects this. Upon notification of the new docket entry, the filer is to print the issued summons in order to effect service. (Attachments: #1 summons - Glaxo Smith, #2 Pfizer, #3 Sanofi)(jae) |
| Filing 5 NOTICE OF RIGHT TO CONSENT TO THE EXERCISE OF CIVIL JURISDICTION BY A MAGISTRATE JUDGE Pursuant to 28 U.S.C. 636(c), Fed.R.Civ.P.73, and Local Rule 72.1, this Court has designated the Magistrate Judges of this District to conduct trials and otherwise dispose of any civil case that is filed in this Court. Your decision to consent, or not consent, to the referral of your case to a United States Magistrate Judge for trial and entry of a final judgment must be entirely voluntary. The judge or magistrate judge to whom the case has been assigned will not be informed of your decision unless all parties agree that the case may be referred to a magistrate judge for these specific purposes. A less than unanimous decision will not be communicated by this office to either the judge or magistrate judge. The consent form is available on the courts website at https://www.tnwd.uscourts.gov/forms-and-applications.php (jae) |
| Filing 4 NOTICE TO COMPLY WITH PLAN FOR ALTERNATE DISPUTE RESOLUTION (ADR): Pursuant to Section to 2.1 of the ADR Plan, all civil cases filed on or after Sept. 1, 2014, shall be referred automatically for ADR. For compliance requirements, refer to the ADR Plan at: http://www.tnwd.uscourts.gov/pdf/content/ADRPlan.pdf (jae) |
| Filing 3 NOTICE OF CASE TRACKING ASSIGNMENT PURSUANT TO LOCAL RULE 16.2: Pursuant to Local Rule 16.2, this case has been assigned to the Standard track. http://www.tnwd.uscourts.gov/pdf/content/LocalRules.pdf (jae) |
| Filing 2 Judge Sheryl H. Lipman and Magistrate Judge Charmiane G. Claxton added. (jae) |
| Filing 1 COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services, Inc. (Filing fee $ 400 receipt number ATNWDC-3297284), filed by Curtis Allen. (Attachments: #1 Civil Cover Sheet, #2 Summons Boehringer Ingelheim Pharmaceuticals, Inc., #3 Summons Sanofi US Services, Inc., #4 Summons Pfizer, Inc., #5 Summons GlaxoSmithKline, LLC)(Herring, Andrew) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Tennessee Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
